The molecular mechanisms of miR‐375 dysregulation in SMA are unknown at present; however, it was hypothesized that FUS loss‐of‐function mutations in ALS are responsible for FUS protein discharge from the nucleus and interruption of miR‐375 synthesis. The gene discussed is FUS; the disease is amyotrophic lateral sclerosis.